Ziemssen, Tjalf

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid

Schläger, C., Körner, H., Krueger, M., Vidoli, S., Haberl, M., Mielke, D., Brylla, E., Issekutz, T., Cabañas, C., Nelson, P. J., et al. (2016) · Nature

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 372

Spectral Analysis of Heart Rate Variability: Time Window Matters

Li, K., Rüdiger, H., & Ziemssen, T. (2019) · Frontiers in Neurology

Heart Rate Variability and Autonomic ControlECG Monitoring and Analysis

Cited by 215

A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity

Chung, K.-J., Chatzigeorgiou, A., Economopoulou, M., Garcia-Martin, R., Alexaki, V. I., Mitroulis, I., Nati, M., Gebler, J., Ziemssen, T., Goelz, S. E., et al. (2017) · Nature Immunology

Adipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Cited by 175

Glatiramer acetate: Mechanisms of action in multiple sclerosis

Schrempf, W., & Ziemssen, T. (2007) · Autoimmunity Reviews

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 168

Glatiramer acetate: mechanisms of action in multiple sclerosis.

Ziemssen, T., & Schrempf, W. (2007) · International review of neurobiology

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 135

Loss of nocturnal blood pressure fall in various extrapyramidal syndromes

Schmidt, C., Berg, D., Herting, Prieur, S., Junghanns, S., Schweitzer, K., Globas, C., Schöls, L., Reichmann, H., & Ziemssen, T. (2009) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsCardiovascular Syncope and Autonomic Disorders

Cited by 113

Evidence-based patient information programme in early multiple sclerosis: a randomised controlled trial

Kopke, S., Kern, S., Ziemssen, T., Berghoff, M., Kleiter, I., Marziniak, M., Paul, F., Vettorazzi, E., Pottgen, J., Fischer, K., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry

Multiple Sclerosis Research StudiesPatient-Provider Communication in Healthcare

Cited by 77

Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis

Kern, S., Schrempf, W., Schneider, H., Schultheiß, T., Reichmann, H., & Ziemssen, T. (2009) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesCancer survivorship and care

Cited by 65

Cortisol awakening response is linked to disease course and progression in multiple sclerosis

Kern, S., Krause, I., Horntrich, A., Thomas, K., Aderhold, J., & Ziemssen, T. (2013) · PLoS ONE

Multiple Sclerosis Research StudiesStress Responses and Cortisol

Cited by 50

Review: Brain—immune communication psychoneuroimmunology of multiple sclerosis

Kern, S., & Ziemssen, T. (2008) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesTryptophan and brain disorders

Cited by 45

Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies

Akgün, K., Essner, U., Seydel, C., & Ziemssen, T. (2019) · Journal of Central Nervous System Disease

Cannabis and Cannabinoid ResearchBotulinum Toxin and Related Neurological Disorders

Cited by 28